Neovasc Inc (US) Company Profile (NASDAQ:NVCN)

About Neovasc Inc (US) (NASDAQ:NVCN)

Neovasc Inc (US) logoNeovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NVCN
  • CUSIP: N/A
  • Web:
  • Market Cap: $113.61 million
  • Outstanding Shares: 78,897,000
Average Prices:
  • 50 Day Moving Avg: $1.57
  • 200 Day Moving Avg: $1.46
  • 52 Week Range: $0.39 - $3.34
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.58
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $8.99 million
  • Price / Sales: 12.64
  • Book Value: ($0.28) per share
  • Price / Book: -5.14
  • EBIDTA: ($24,550,000.00)
  • Net Margins: -1,423.84%
  • Return on Equity: -741.55%
  • Return on Assets: -68.95%
  • Current Ratio: 0.32%
  • Quick Ratio: 0.31%
  • Average Volume: 777,608 shs.
  • Beta: -0.13
  • Short Ratio: 2.4

Frequently Asked Questions for Neovasc Inc (US) (NASDAQ:NVCN)

What is Neovasc Inc (US)'s stock symbol?

Neovasc Inc (US) trades on the NASDAQ under the ticker symbol "NVCN."

How were Neovasc Inc (US)'s earnings last quarter?

Neovasc Inc (US) (NASDAQ:NVCN) released its quarterly earnings data on Tuesday, March, 29th. The company reported ($0.11) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.04. The business earned $2.24 million during the quarter, compared to analyst estimates of $3.26 million. Neovasc Inc (US) had a negative net margin of 1,423.84% and a negative return on equity of 741.55%. View Neovasc Inc (US)'s Earnings History.

Where is Neovasc Inc (US)'s stock going? Where will Neovasc Inc (US)'s stock price be in 2017?

4 analysts have issued twelve-month target prices for Neovasc Inc (US)'s shares. Their predictions range from $4.00 to $10.00. On average, they anticipate Neovasc Inc (US)'s share price to reach $6.50 in the next year. View Analyst Ratings for Neovasc Inc (US).

Who are some of Neovasc Inc (US)'s key competitors?

Who are Neovasc Inc (US)'s key executives?

Neovasc Inc (US)'s management team includes the folowing people:

  • Paul L. Geyer, Independent Chairman of the Board
  • Alexei J. Marko, Chief Executive Officer, Director
  • Christopher Clark, Chief Financial Officer, Corporate Secretary
  • Brian McPherson, Chief Operating Officer
  • Vicki Lee Bebeau, Vice President - Clinical Affairs
  • Randy Lane, Vice President - Research & Development
  • Jane H. Hsiao Ph.D., Independent Director
  • Douglas Glen Janzen, Independent Director
  • William O'Neill, Independent Director
  • Steven D. Rubin Esq.,J.D., Independent Director

Who owns Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock is owned by many different of institutional and retail investors. Top institutional investors include West Family Investments Inc. (3.81%), Gagnon Securities LLC (3.65%), Gagnon Advisors LLC (1.53%), Bailard Inc. (0.72%), Iguana Healthcare Management LLC (0.42%) and Candriam Luxembourg S.C.A. (0.13%). View Institutional Ownership Trends for Neovasc Inc (US).

Who sold Neovasc Inc (US) stock? Who is selling Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock was sold by a variety of institutional investors in the last quarter, including Gagnon Securities LLC. View Insider Buying and Selling for Neovasc Inc (US).

Who bought Neovasc Inc (US) stock? Who is buying Neovasc Inc (US) stock?

Neovasc Inc (US)'s stock was purchased by a variety of institutional investors in the last quarter, including West Family Investments Inc. and Iguana Healthcare Management LLC. View Insider Buying and Selling for Neovasc Inc (US).

How do I buy Neovasc Inc (US) stock?

Shares of Neovasc Inc (US) can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Neovasc Inc (US)'s stock price today?

One share of Neovasc Inc (US) stock can currently be purchased for approximately $1.44.

MarketBeat Community Rating for Neovasc Inc (US) (NASDAQ NVCN)
Community Ranking:  2.9 out of 5 ( )
Outperform Votes:  81 (Vote Outperform)
Underperform Votes:  57 (Vote Underperform)
Total Votes:  138
MarketBeat's community ratings are surveys of what our community members think about Neovasc Inc (US) and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Neovasc Inc (US) (NASDAQ:NVCN) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.50 (351.39% upside)

Analysts' Ratings History for Neovasc Inc (US) (NASDAQ:NVCN)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/5/2017Ladenburg Thalmann Financial ServicesUpgradeNeutral -> Buy$4.00HighView Rating Details
4/3/2017JMP SecuritiesReiterated RatingOutperform$5.00MediumView Rating Details
3/23/2017Leerink SwannReiterated RatingOutperformHighView Rating Details
7/12/2016Canaccord GenuityReiterated RatingBuy$7.00N/AView Rating Details
(Data available from 5/29/2015 forward)


Earnings History for Neovasc Inc (US) (NASDAQ:NVCN)
Earnings by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)
Earnings History by Quarter for Neovasc Inc (US) (NASDAQ:NVCN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/14/2016Q216($0.06)($0.12)$2.20 million$3.03 millionViewN/AView Earnings Details
3/29/2016Q415($0.15)($0.11)$3.26 million$2.24 millionViewN/AView Earnings Details
11/9/2015Q3 2015($0.10)($0.11)$3.46 million$2.48 millionViewN/AView Earnings Details
8/6/2015Q2 2015($0.10)($0.10)$3.19 million$2.93 millionViewN/AView Earnings Details
5/12/2015Q115($0.05)($0.08)$3.84 million$2.86 millionViewN/AView Earnings Details
3/30/2015Q414($0.06)($0.11)$3.31 million$3.35 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Neovasc Inc (US) (NASDAQ:NVCN)
2017 EPS Consensus Estimate: ($0.12)
2018 EPS Consensus Estimate: ($0.04)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.09)($0.09)($0.09)
Q2 20171($0.01)($0.01)($0.01)
Q3 20171($0.01)($0.01)($0.01)
Q4 20171($0.01)($0.01)($0.01)
Q1 20181($0.01)($0.01)($0.01)
Q2 20181($0.01)($0.01)($0.01)
Q3 20181($0.01)($0.01)($0.01)
Q4 20181($0.01)($0.01)($0.01)
(Data provided by Zacks Investment Research)


Dividend History for Neovasc Inc (US) (NASDAQ:NVCN)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Neovasc Inc (US) (NASDAQ:NVCN)
No insider trades for this company have been tracked by


Headline Trends for Neovasc Inc (US) (NASDAQ:NVCN)
Latest Headlines for Neovasc Inc (US) (NASDAQ:NVCN)
DateHeadline logoQ2 2017 EPS Estimates for Neovasc Inc (US) (NVCN) Lifted by Leerink Swann - May 15 at 7:33 AM logoNeovasc Inc (US) (NVCN) Lowered to "Hold" at Zacks Investment Research - May 13 at 2:44 PM logoFY2019 Earnings Estimate for Neovasc Inc (US) (NVCN) Issued By Leerink Swann - May 12 at 6:36 PM logoNeovasc's (NVCN) CEO Alexei Marko on Q1 2017 Results - Earnings Call Transcript - May 11 at 12:11 AM logoNeovasc Announces Results for the First Quarter of 2017 - May 10 at 7:08 PM logoNeovasc reports 1Q loss - May 10 at 7:08 PM logoInvestor Network: Neovasc Inc. to Host Earnings Call - May 10 at 11:58 AM logoNeovasc Inc (US) (NVCN) Receives Coverage Optimism Score of 0.31 - May 5 at 10:35 PM logoPerkinElmer (PKI) Tops Q1 Earnings Estimates, FY17 View Up - May 5 at 9:05 AM logoWright Medical (WMGI) Posts Wider-than-Expected Loss in Q1 - May 5 at 9:05 AM logoEcolab (ECL) Q1 Earnings Miss Estimates, Revenues In Line - May 2 at 11:18 AM logoNeovasc Inc (US) (NVCN) Earning Positive News Coverage, Study Finds - May 1 at 5:06 PM logoNeovasc to Host First Quarter 2017 Conference Call - May 1 at 12:12 PM logoNeovasc Inc (US) (NVCN) Receiving Somewhat Positive Press Coverage, Report Finds - April 28 at 5:34 PM logoShort Interest in Neovasc Inc (US) (NVCN) Expands By 9.3% - April 24 at 7:20 PM logoNeovasc Inc (US) (NVCN) Given Daily Media Impact Score of 0.37 - April 24 at 4:14 PM logoNeovasc Inc (US) (NVCN) Receiving Favorable Press Coverage, Analysis Finds - April 21 at 7:12 PM logoIs This Investment Too Risky? - Seeking Alpha - April 19 at 10:11 AM logoNeovasc Inc (US) (NVCN) Earns Daily Media Sentiment Rating of 0.44 - April 16 at 12:37 PM logoWill Neovasc (NVCN) Continue to Surge Higher? - April 7 at 11:35 AM logoNeovasc Inc (US) (NVCN) Stock Rating Upgraded by Ladenburg Thalmann Financial Services - April 5 at 2:13 PM logoJMP Securities Reiterates Outperform Rating for Neovasc Inc (US) (NVCN) - April 3 at 1:18 PM logoNEOVASC INC Financials - March 29 at 7:38 PM logoNeovasc Inc (US)'s (NVCN) "Outperform" Rating Reaffirmed at Leerink Swann - March 29 at 7:01 AM logoNeovasc Inc (US) (NVCN) Stock Rating Reaffirmed by Leerink Swann - March 25 at 7:38 AM logoEarnings Scheduled For March 23, 2017 - Benzinga - March 24 at 12:44 AM logoNeovasc Announces Results for the Fourth Quarter and Fiscal Year 2016 - March 23 at 7:27 PM logoForm 6-K NEOVASC INC For: Mar 14 - - - March 14 at 6:01 PM logoNeovasc to Host Fourth Quarter and Fiscal Year 2016 Conference Call - March 14 at 10:36 AM logoNeovasc Announces TSX Symbol Change to NVCN - PR Newswire (press release) - March 10 at 8:42 PM logoNeovasc Announces TSX Symbol Change to NVCN - March 10 at 9:22 AM logoNeovasc to Present at the Leerink Partners Global Healthcare Conference - February 16 at 6:29 PM logoNeovasc (NVCN) Offers Update in Litigation with CardiAQ - - January 19 at 5:35 AM logoNeovasc (NVCN) Offers Update in Litigation with CardiAQ - January 18 at 7:31 PM logo2:07 pm Neovasc updates in its ongoing litigation with CardiAQ Valve Technologies - January 18 at 7:31 PM logoNeovasc (NVCN) Confirms Judgement Stayed in CardiAQ Case; to Deposit $70M in Escrow - December 23 at 7:06 PM



Neovasc Inc (US) (NVCN) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by Staff